Search

everythinglearnresearchcommunity

for

Search:↓

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

A man's chest hair turned white after a shingles infection, possibly due to virus-damaged pigment cells.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Herbal preparation effectively promotes hair growth and reduces hair loss.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Finasteride causes reduced tear flow and severe eye inflammation.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

New hair transplant method allows for hair regrowth in the donor area and less scarring.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Microemulsions could improve how drugs are delivered and absorbed in the body.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.